APP and Alzheimer disease: Moreover, an intrinsic α-secretase inhibitor is elevated in brains of patients with sporadic AD at various stages, and the knockout of this inhibitor in APP/PS1 AD model mice promotes anti-amyloidogenic α-cleavage of APP, thereby reducing Aβ (Esteve et al., 2019).